The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 45, Issue 1-2, 2009, Pages 69-74

  Zhuo, Zhihong ^a   Zhang, Leming ^a,b   Mu, Qitian ^b   Lou, Yanru ^b   Gong, Zhaohui ^a   Shi, Yijiu ^b   Ouyang, Guifang ^b   Zhang, Yi ^b  

^a NINGBO UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

Author keywords

5 Fluorouracil; BCL2L12; Caspases; Docosahexaenoic acid; Gastric neoplasm

Indexed keywords

DOCOSAHEXAENOIC ACID; FLUOROURACIL; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BCL 2 GENE; BCL2L12 GENE; CANCER CELL CULTURE; CASPASE 9 GENE; CONTROLLED STUDY; DRUG POTENTIATION; FAS GENE; GENE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLUOROURACIL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MUSCLE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 69049114085     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-008-9154-5     Document Type: Article

References (24)

1. J. M. Adams 2003 Ways of dying: multiple pathways to apoptosis Genes & Dev. 17 2481 2495. doi:10.1101/gad.1126903.
2. P. Bougnoux N. Hajjaji M. A. Baucher M. L. Jourdan C. Goupille G. Body O. L. Floch 2006 Docosahexaenoic acid (DHA) intake during first line chemotherapy improves survival in metastatic breast cancer Proc Amer Assoc Cancer Res 47 1237
3. M. O. Bradley N. L. Webb F. H. Anthony P. Devanesan P. A. Witman S. Hemamalini M. C. Chander S. D. Baker L. He S. B. Horwitz C. S. Swindel 2001 Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel Clin Cancer Res 7 3229 3238
4. G. Calviello F. D. Nicuolo S. Serini E. Piccioni A. Boninsegna N. Maggiano F. O. Ranelletti P. Palozza 2005 Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil Cancer Chemother Pharmacol 55 12 20. doi:10.1007/s00280-004-0846-6.
5. G. Calviello F. Resci S. Serini E. Piccioni A. Toesca A. Boninsegna G. Monego F. O. Ranelletti P. Palozza 2007 Docosahexaenoic acid induces proteasome-dependent degradation of ß-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2 Carcinogenesis 28 1202 1209. doi:10.1093/carcin/bgl254.
6. M. C. Cha A. Aldred C. Stewart K. A. Meckling 2002 Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice Nutr Cancer 44 175 181. doi:10.1207/ S15327914NC4402-09.
7. N. Danbara T. Yuri M. Tsujita-Kyutoku M. Sato H. Senzaki H. Takada T. Hada T. Miyazawa K. Okazaki A. Tsubura 2004 Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of Colo 201 human colon cancer cells Nutr Cancer 50 71 79. doi:10.1207/s15327914nc5001- 10.
8. Q. N. Diep R. M. Touyz E. L. Schiffrin 2000 Docosahexaenoic acid, a peroxisome proliferator-activated receptor-a ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase Hypertension 36 851 855
9. W. Q. Ding S. E. Lind 2007 Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity Mol Cancer Ther 6 1467 1474. doi:10.1158/1535-7163. MCT-06-0608.
10. K. V. Floros H. Thomadaki N. Katsaros M. Talieri A. Scorilas 2004 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin Biol Chem 385 1099 1103. doi:10.1515/BC.2004.143.
11. H. Gleissman M. Lindskog F. Ponthan L. Elfman J. I. Johnsen P. Kigner 2006 Omega-3 docosahexaenoic acid inhibits neuroblastoma cell growth in vivo Proc Amer Assoc Cancer Res 47 1019
12. E. Horia B. A. Watkins 2007 Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells Carcinogenesis 28 809 815. doi:10.1093/carcin/bgl183.
13. T. Kato R. S. Pardini 2005 Marine source ω-3 fatty acid, docosahexaenoic acid (DHA), inhibits human colorectal cancer growth through multiple mechanisms depending on the mutational status of p53 protein Proc Amer Assoc Cancer Res 46 1046
14. M. Lee M. A. Bae 2007 Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage J Nutr Biochem 18 348 354. doi:10.1016/j.jnutbio. 2006.06.003.
15. K. Lim C. Han L. Xu K. Isse A. J. Demetris T. Wu 2008 Cyclooxygenase-2-derived prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by ω-3 polyunsaturated fatty acids Cancer Res 68 553 560. doi:10.1158/0008-5472.CAN-07-2295.
16. D. D. Newmeyer M. S. Fergusson 2003 Mitochondria: releasing power for life and unleashing the machineries of death Cell 112 481 490. doi:10.1016/S0092-8674(03)00116-8.
17. Y. Ng R. Barhoumi R. B. Tjalkens Y. Y. Fan S. Kolar N. Wang J. R. Lupton R. S. Chapkin 2005 The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes Carcinogenesis 26 1914 1921. doi:10.1093/carcin/bgi163.
18. M. Okamura M. Kobayashi F. Suzuki J. Shimada H. Sakagami 2007 Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line Anticancer Res 27 3331 3337
19. A. Scorilas L. Kyriakopoulou G. M. Yousef L. K. Ashworth A. Kwamie E. P. Diamandis 2001 Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family Genomics 72 217 221. doi:10.1006/geno.2000.6455.
20. P. D. Schley D. N. Brindley C. J. Field 2007 (N-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells J Nutr 137 548 553
21. ® on hormone refractory prostate cancer cell line PC-3 growth in vivo Proc Amer Assoc Cancer Res 47 914
22. A. H. Stegh H. Kim R. M. Bachoo K. L. Forloney J. Zhang H. Schulze K. Park G. J. Hannon J. Yuan D. N. Louis R. A. DePinho L Chin 2007 BCL2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma Genes Dev 21 98 111. doi:10.1101/gad.1480007.
23. A. C. Wolff R. C. Donehower M. K. Carducci M. A. Carducci J. R. Brahmer Y. Zabelina M. O. Bradley F. H. Anthony C. S. Swindell P. A. Witman N. L. Webb S. D. Baker 2003 Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile Clin Cancer Res 9 3589 3597
24. M. Wu K. A. Harvey N. Ruzmetov Z. R. Welch L. Sech K. Jackson W. Stillwell G. P. Zaloga R. A. Siddiqui 2006 Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway Int J Cancer 117 340 348. doi:10.1002/ijc. 21238.